Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold... see more

Bullboard (TSXV:COV)

View:
Post by mcapproon Aug 21, 2024 7:20am

Covalon Announces Strong Third Quarter Fiscal 2024 Results

https://ir.covalon.com/news/news-details/2024/Covalon-Announces-Strong-Third-Quarter-Fiscal-2024-Results/default.aspx
User Avatar Image
(1783)
•••
  • Possibleidiot01X
Post by Possibleidiot01on Aug 09, 2024 6:19pm

Stocks & Stones blog - August 6th

Underdog to Watch: Covalon Technologies (TSX-V: COV)   Covalon is a medical device company that provides patented, innovative, and cost-effective solutions for wound care, infection ...more  
User Avatar Image
(1783)
•••
  • Possibleidiot01X
Comment by Possibleidiot01on Jun 13, 2024 4:40pm

RE:Q2 FINS Review (3.25 / 5)

Really appreciated this review ; helped crystallize my thoughts. Thanks
User Avatar Image
(292)
•••
  • WolfOakvilleX
Post by WolfOakvilleon Jun 12, 2024 9:21am

Q2 FINS Review (3.25 / 5)

"If you could convince me the company I'm looking at in Q2 is the company I'll get for the next six quarters, I'd be interested, but I'm not sure you can." Full Review ...more  
Post by mcapproon Jun 03, 2024 7:09am

Correction to previous post - see updated links

https://events.q4inc.com/attendee/221238520 https://s202.q4cdn.com/814608179/files/doc_financials/2024/q2/2024-Q2-Earnings-Presentation-v2-2-20240528-1400.pdf
Post by mcapproon Jun 03, 2024 7:03am

Link to Covalon Earnings Webcast - Q2 Results

https://drive.google.com/file/d/10PasFVbE9zCRB-V71jpfk78QPnYr-skP/view
User Avatar Image
(175)
•••
  • prophetoffactzX
Post by prophetoffactzon May 29, 2024 10:34am

A stunning turn

And the conference call this morning appeared quite positive with cash expected to continue to grow. Covalon Announces Profitable Second Quarter Fiscal 2024 Results    ...more  
User Avatar Image
(11)
•••
  • LTNvestorX
Post by LTNvestoron May 29, 2024 7:28am

Covalon Announces Profitable Second Quarter F2024 Results

https://ir.covalon.com/news/news-details/2024/Covalon-Announces-Profitable-Second-Quarter-Fiscal-2024-Results/default.aspx
User Avatar Image
(1783)
•••
  • Possibleidiot01X
Post by Possibleidiot01on May 23, 2024 10:19am

more Mathieu Martin

  Forwarded this email? Subscribe here for more  ...more  
User Avatar Image
(1783)
•••
  • Possibleidiot01X
Post by Possibleidiot01on May 01, 2024 7:10am

Mathieu Martin Oct 20, 2023

Covalon Technologies (TSX-V: COV) https://stocksandstones.substack.com/p/flurry-of-acquisitions Covalon is a medical device company in the wound care space. They already ran a strategic ...more  
Comment by ARIMA11on Feb 02, 2024 5:45pm

RE:Impressive looking financial results

Still... Net Loss of (4.4M) in FY2023 and (2.8M) in Q4 2023.  Also from 22.9M in cash Q4 2021 to 8.79M in Q4 2023. Bottom line is the bottom line need to increase. How much more cash burn to be ...more  
User Avatar Image
(9)
•••
  • bronkrdrX
Post by bronkrdron Jan 29, 2024 1:33pm

Impressive looking financial results

Revenue for the year ended September 30, 2023 increased 47% to $26.6M compared to $18.1M for the same period of the prior year. Product revenue for the year ended September 30, 2023 increased 46% to ...more  
Comment by ARIMA11on Jan 05, 2024 11:10am

RE:new CEO

Ok. Now we're talkin. Sustainability and Profitability. Also compensation is aligned with shareolders. Great addition (an outsider) which was much needed here. Let's see how it goes.
User Avatar Image
(1783)
•••
  • Possibleidiot01X
Post by Possibleidiot01on Jan 04, 2024 7:37am

new CEO

Exercise price 20% above current price. Seems very well qualified. Mr. Ashton will be granted 800,000 stock options that will vest equally over four years at an exercise price equal to the greater ...more  
Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities